Home Healthcare Medical Devices High Intensity Focused Ultrasound Market

High Intensity Focused Ultrasound Market Size, Share & Trends Analysis Report By Method (Non invasive, Minimally Invasive), By Application (Uterine Fibroids, Prostate Cancer, Essential Tremor, Dermatology, Breast Cancer, Glaucoma, Others), By End Use (Hospitals, Imaging Centers, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 24, 2026 | Author: Debashree Bora | Format:

High Intensity Focused Ultrasound Market Size

The global high intensity focused ultrasound market size was valued at USD 1.4 billion in 2025 and is projected to grow from USD 1.50 billion in 2026 to USD 2.60 billion by 2034, registering a CAGR of 7.12% during the forecast period from 2026 to 2034. North America dominated the high intensity focused ultrasound market with a market share of 31.21% in 2025.

The global high intensity focused ultrasound market comprises a diverse range of therapeutic methods, including non-invasive and minimally invasive techniques designed to deliver precise, targeted energy for tissue ablation and neuromodulation. HIFU is widely applied across multiple clinical areas such as uterine fibroids, prostate cancer, essential tremor, dermatology, breast cancer, glaucoma, and other indications. These procedures are performed across hospitals, imaging centers, and other healthcare facilities, supporting broad clinical adoption and expanding patient access to advanced non-surgical treatment options.

Market Key Takeaways

Global Market Size & Growth

North America dominated the global market, accounting for a 31.21% share in 2025.
The Asia Pacific region is projected to grow at the fastest pace, with a CAGR of 41%.
Based on the method, the non-invasive segment dominated the market with a revenue share of 41.39% in 2025.
By application, the dermatology segment dominated the market with a revenue share of
Based on end use, the hospitals segment dominated the market in 2025 with a revenue share of 43.65%.
The U.S. dominates the market, valued at USD 371.43 million in 2024 and reaching USD 396.28 million in 2025.
2025 Market Size
USD 1.40 billion
2034 Projected Market Size
USD 2.61 billion
CAGR (2026-2034)
7.12%
Dominating Region
North America
Fastest-Growing Region
Asia Pacific
High Intensity Focused Ultrasound Market Size

Download a Free Sample To learn more about this report.

By Method

The non-invasive segment dominated the market in 2025, owing to its ability to minimize surgical risks and reduce hospital stay durations. Patients increasingly prefer procedures that offer effective treatment with faster recovery, driving demand for non-invasive HIFU therapies across multiple indications.

The minimally invasive segment is estimated to register the fastest CAGR of 8.91% during the forecast period, due to advancements in precision-guided HIFU instruments that enable targeted tissue ablation with minimal trauma, improving procedural efficiency and patient comfort across diverse clinical applications.

High Intensity Focused Ultrasound Market Size By Segments

Request Customizationto receive a tailored report.

By Application

The dermatology segment dominated the market in 2025, accounting for 21.42% revenue share. This growth is driven by rising demand for non-invasive cosmetic procedures, including skin tightening, scar reduction, and fat reduction, where HIFU offers effective results with minimal downtime.

The prostate cancer segment is estimated to register the fastest CAGR of 8.28% during the forecast period. This growth is attributed to rising preference for outpatient, organ-preserving treatments, with HIFU offering precise tumor targeting while minimizing complications and preserving urinary and sexual functions.

By End Use

The hospitals segment dominated the market with the highest revenue share of 43.65% in 2025. This growth is supported by hospitals’ ability to offer multi-disciplinary HIFU services, combining advanced imaging, skilled specialists, and comprehensive post-procedure care, ensuring higher treatment adoption.

The imaging centers segment is projected to register the fastest CAGR from 2026-2034, due to the increasing availability of dedicated outpatient HIFU units equipped with advanced ultrasound and MRI imaging, enabling high precision, efficient treatments in specialized settings.

High Intensity Focused Ultrasound Market Share By Segments

Speak to an Analystto discuss market opportunities.

Regional Analysis

North America dominated the high intensity focused ultrasound market in 2025, accounting for 31.21% market share. This growth is augmented by strong presence of leading HIFU manufacturers and research institutions, in drives market growth by fostering innovation, facilitating clinical trials, and ensuring early adoption of advanced focused ultrasound technologies.

U.S. market growth is driven by substantial government and private funding for clinical research, which accelerates the development and adoption of innovative HIFU technologies. This support enables advanced clinical trials, technology refinement, and wider integration of HIFU in hospitals and specialty centers.

North America High Intensity Focused Ultrasound Market Revenue Share 2025

Unlock Regional Insightsto access country-level data, & regional trends.

Asia Pacific Market Insights

Asia Pacific is emerging as the fastest-growing region with a CAGR of 8.41% from 2026 to 2034, owing to the rapid expansion of private healthcare facilities and increased government initiatives promoting advanced non-invasive treatments. This is enhancing patient access to HIFU therapies across oncology, gynecology, and neurology.

Australia high intensity focused ultrasound market growth is supported by increasing investments in advanced medical technologies and growing adoption of outpatient non-invasive procedures. The presence of well-equipped private clinics and research institutions enables wider access to HIFU treatments, driving market expansion across oncology and women’s health applications.

Europe High Market Insights

Europe high intensity focused ultrasound market is boosted by the rising geriatric population and the increasing prevalence of chronic conditions such as prostate cancer and uterine fibroids. Growing patient demand for non-invasive, precise treatment options encourages healthcare providers to adopt HIFU technologies, supporting regional market expansion.

In UK, the market is experiencing notable growth, driven by increasing adoption of private healthcare services and specialized outpatient clinics. These facilities offer advanced HIFU treatments with shorter waiting times, improving patient access and encouraging wider acceptance of non-invasive therapeutic procedures.

Latin America Market Insights

Latin America’s market is being driven by rising adoption of medical tourism, where patients seek advanced non-invasive treatments at competitive costs. Countries like Brazil and Mexico are increasingly offering HIFU therapies, attracting both domestic and international patients, thereby boosting market growth.

The growth of Brazil's high-intensity focused ultrasound market is driven by growing awareness and demand for minimally invasive cosmetic and dermatology procedures. Clinics in major cities are increasingly offering HIFU-based skin tightening, fat reduction, and scar treatment services, attracting a growing patient base and contributing to market expansion.

Middle East and Africa Market Insights

The Middle East and Africa high intensity focused ultrasound market growth is stimulated by the increasing prevalence of lifestyle-related diseases, including prostate and breast cancer. Growing patient demand for non-invasive, precise treatment options encourages hospitals and clinics to adopt HIFU technologies, supporting regional market expansion.

South Africa high-intensity focused ultrasound market growth is supported by increasing collaboration between local hospitals and international HIFU technology providers. These partnerships facilitate technology transfer, clinician training, and pilot programs, enabling early adoption of advanced non-invasive therapies for oncology and gynecology, and creating a niche growth pathway.

Competitive Landscape

The global high intensity focused ultrasound market is moderately consolidated, with a mix of established medical device manufacturers and emerging innovators shaping the competitive landscape. Leading players such as Insightec Ltd., EDAP TMS S.A., Chongqing Haifu Medical Technology, and HistoSonics maintain strong market positions through technological advancements, regulatory approvals, and expanding clinical applications. Continuous R&D investment, strategic partnerships, and growing adoption of non-invasive therapies further enhance competition across key therapeutic segments.

HistoSonics: An emerging market player

HistoSonics is rapidly emerging in the market with its novel histotripsy technology, a non-thermal, non-invasive therapeutic approach that mechanically destroys targeted tissues with high precision. The company gained strong investor confidence, supported by substantial funding rounds and expanding clinical trials across liver and kidney tumor applications.

  • In 2024, HistoSonics advanced its Edison system into broader commercial rollout following favorable clinical results and regulatory progress. Thus, HistoSonics is positioning itself as a transformative emerging player in the HIFU landscape.

List of Key and Emerging Players in High Intensity Focused Ultrasound Market

Alpinion Medical Systems
AMI Technologies Ltd.
Arrayus Technologies Inc.
Bracco
Chongqing Haifu Medical Technology
Chengji Electronic Technology
EDAP TMS S.A.
Elekta
GE HealthCare
HistoSonics
Hitachi, Ltd.
Insightec Ltd.
Koninklijke Philips N.V.
Profound Medical
Shenzhen Promethe Medical Sci-Tech Co.
Theraclion S.A.
Advanced Microbubbles, Inc.
Others

Key Industry Developments

March 2026
Insightec expanded its focused ultrasound technology portfolio with advanced Exablate systems designed for non-invasive treatments in neurology and oncology applications, improving precision and patient outcomes.
January 2026
EDAP TMS expanded its high-intensity focused ultrasound solutions with enhanced Focal One technology, supporting minimally invasive prostate cancer treatments and improving targeted therapy capabilities.
October 2025
Sonablate expanded its focused ultrasound therapy portfolio with upgraded HIFU systems designed for urological procedures, enabling precise tissue ablation and improved clinical workflows.
August 2025
Profound Medical expanded its TULSA-PRO® focused ultrasound platform with advanced treatment capabilities for prostate disease management, supporting image-guided and personalized therapeutic approaches.

Report Scope

Segmentation

By Method 2
  • Non invasive
  • Minimally Invasive
By Application 7
  • Uterine Fibroids
  • Prostate Cancer
  • Essential Tremor
  • Dermatology
  • Breast Cancer
  • Glaucoma
  • Others
By End Use 3
  • Hospitals
  • Imaging Centers
  • Others

Geographies Covered

North America 2
  • U.S.
  • Canada
Europe 8
  • U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Russia
  • Nordic
  • Benelux
APAC 7
  • China
  • Korea
  • Japan
  • India
  • Australia
  • Taiwan
  • South East Asia
Middle East and Africa 6
  • UAE
  • Turkey
  • Saudi Arabia
  • South Africa
  • Egypt
  • Nigeria
LATAM 5
  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Colombia
Competitive Coverage Alpinion Medical Systems · AMI Technologies Ltd. · Arrayus Technologies Inc. · Bracco · Chongqing Haifu Medical Technology
Research Deliverables Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Customize This Report to Match Your Strategic Objectives

Frequently Asked Questions (FAQs)

The high intensity focused ultrasound market size is valued at USD 1.50 Billion in 2026 and is projected to reach USD 2.60 Billion by 2034, at a CAGR of 7.12% during the forecast period 2026-2034.

North America dominated the market with a share of 31.21% in 2025.

The leading players in this market are Alpinion Medical Systems, AMI Technologies Ltd., Arrayus Technologies Inc., Bracco, Chongqing Haifu Medical Technology.

The high intensity focused ultrasound market is projected to grow at a CAGR of 7.12% during the forecast period of 2026 2034.
About the Author
Debashree Bora
Debashree Bora
Healthcare Lead

Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, and competitive dynamics.
Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.

Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Request Sample Order Report Now

We are featured on: